Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2467${count})

  • LRRK2 Biology Consortium, 2017
    Describing the Structure and Function of LRRK2

    Study Rationale:
    Although leucine-rich repeat kinase 2 (LRRK2) is the greatest known genetic contributor to Parkinson's disease (PD), little is known about its structure and function. To better...

  • Research Grant, 2017
    Using Neural Cells to Test New Drugs that Activate PINK1 and Parkin

    Promising Outcomes of Original Grant:
    Even though most people with Parkinson's disease (PD) do not have a genetic mutation -- a change in their DNA -- that causes the disease, genes can influence the...

  • Research Grant, 2017
    Radioactive Molecules for Detection of Alpha-synuclein and Amyloid-beta in the Brain

    Study Rationale:
    We will develop radioactive alpha-synuclein and beta-amyloid tracers -- molecules that allow researchers and clinicians to detect these two proteins in the brain using imaging...

  • Access to Data & Biospecimens, 2017
    Klotho and Parkinson’s disease

    Study Rationale:                   

    Genetic studies have identified a powerful “aging suppressor gene”, Klotho, that may play a role in delaying age-related declines in cellular and tissue functioning...

  • LRRK2 Biology Consortium, 2017
    The Role of Variations in the LRRK2 Gene in Parkinson's Disease

    Study Rationale:
    Genes can influence one's chance of developing Parkinson's disease (PD), but it's not entirely clear how. In this study, we will use cells from people with Parkinson's to test how the...

  • Access to Data and Biospecimens, 2017
    LRRK2 in predicting Parkinson disease risk and progression in LRRK2 mutation carriers

    Study Rationale:       

    The G2019S mutation in the LRRK2 gene is responsible for thousands Parkinson disease (PD) cases. But, not all of the mutation carriers will develop PD. Currently, clinicians...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.